MSH2 (mutS homolog 2) was originally recognized as a regulator in DNA mismatch repair pathway and its strong correlation with elevated PD-L1 expression and immune infiltration was only revealed recently in lung adenocarcinoma (Jia et al. 2020). This evidence concerns the gene MSH2 and lung adenocarcinoma.